×
About 123,800 results

ALLMedicine™ Melanoma Center

Research & Reviews  57,693 results

Parkinson's disease and skin.
https://doi.org/10.1016/j.parkreldis.2020.11.017
Parkinsonism & Related Disorders; Niemann N, Billnitzer A et. al.

Nov 28th, 2020 - Parkinson's disease is associated with a variety of dermatologic disorders and the study of skin may provide insights into pathophysiological mechanisms underlying this common neurodegenerative disorder. Skin disorders in patients with Parkinson's...

Effects of a Time Out Consultation with the general practitioner on cancer treatment de...
https://doi.org/10.1002/pon.5604
Psycho-oncology Perfors IAA, Noteboom EA et. al.

Nov 27th, 2020 - Improving shared decision making (SDM) enables more tailored cancer treatment decisions. We evaluated a Time Out Consultation (TOC) with the general practitioner (GP), between cancer diagnosis and treatment decision, which aims at supporting SDM a...

Vitamins A, B, C, and D: A Short Review for the Dermatologist.
https://www.ncbi.nlm.nih.gov/pubmed/33245705
Alternative Therapies in Health and Medicine; Coerdt KM, Goggins CA et. al.

Nov 27th, 2020 - Vitamins and their derivatives are used extensively in the field of dermatology to treat a range of conditions, both benign and malignant. Additionally, over the past decade, vitamin supplements have been heavily advertised for improving overall h...

Immune checkpoint inhibitor therapy may increase the incidence of treatment-related nec...
https://doi.org/10.1007/s00330-020-07514-0
European Radiology; Kim PH, Suh CH et. al.

Nov 26th, 2020 - To compare the incidence of treatment-related necrosis between combination SRS+ICI therapy and SRS therapy alone in patients with brain metastases from melanoma and non-small cell lung cancer (NSCLC). A systematic literature search of Ovid-MEDLINE...

Clinical Characteristics in Early Childhood Associated with a Nevus-Prone Phenotype in ...
https://doi.org/10.3390/ijerph17228680
International Journal of Environmental Research and Public Health; Barsoum R, Harrison SL

Nov 26th, 2020 - Having numerous melanocytic nevi increases melanoma risk. Few studies have enumerated nevi in children and re-examined them as adults. We aimed to determine if childhood nevus-counts predict nevus-prone adults, and further explore the relevance of...

see more →

Guidelines  177 results

ESMO consensus conference recommendations on the management of locoregional melanoma: u...
https://doi.org/10.1016/j.annonc.2020.07.005
Annals of Oncology : Official Journal of the European Society for Medical Oncology; Michielin O, van Akkooi A et. al.

Aug 8th, 2020 - The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. Th...

ESMO consensus conference recommendations on the management of metastatic melanoma: und...
https://doi.org/10.1016/j.annonc.2020.07.004
Annals of Oncology : Official Journal of the European Society for Medical Oncology; Keilholz U, Ascierto PA et. al.

Aug 8th, 2020 - The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. Th...

ASCO20 Virtual Scientific Program Showcases the Latest Advances in Melanoma Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200224/full/
ASCO Daily News;

Jun 24th, 2020 - The ASCO20 Virtual Scientific Program featured a range of studies showcasing the latest advances and clinical breakthroughs in melanoma research.

see more →

Drugs  61 results see all →

Clinicaltrials.gov  61,593 results

Intron a - interferon alfa-2b kit-Merck Sharp & Dohme Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30789790-8317-49f9-b97b-8c5ba17b53d2

Dec 1st, 2020 - INTRON® A is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia. INTRON A is indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who are free of disease bu...

Parkinson's disease and skin.
https://doi.org/10.1016/j.parkreldis.2020.11.017
Parkinsonism & Related Disorders; Niemann N, Billnitzer A et. al.

Nov 28th, 2020 - Parkinson's disease is associated with a variety of dermatologic disorders and the study of skin may provide insights into pathophysiological mechanisms underlying this common neurodegenerative disorder. Skin disorders in patients with Parkinson's...

Effects of a Time Out Consultation with the general practitioner on cancer treatment de...
https://doi.org/10.1002/pon.5604
Psycho-oncology Perfors IAA, Noteboom EA et. al.

Nov 27th, 2020 - Improving shared decision making (SDM) enables more tailored cancer treatment decisions. We evaluated a Time Out Consultation (TOC) with the general practitioner (GP), between cancer diagnosis and treatment decision, which aims at supporting SDM a...

Vitamins A, B, C, and D: A Short Review for the Dermatologist.
https://www.ncbi.nlm.nih.gov/pubmed/33245705
Alternative Therapies in Health and Medicine; Coerdt KM, Goggins CA et. al.

Nov 27th, 2020 - Vitamins and their derivatives are used extensively in the field of dermatology to treat a range of conditions, both benign and malignant. Additionally, over the past decade, vitamin supplements have been heavily advertised for improving overall h...

Immune checkpoint inhibitor therapy may increase the incidence of treatment-related nec...
https://doi.org/10.1007/s00330-020-07514-0
European Radiology; Kim PH, Suh CH et. al.

Nov 26th, 2020 - To compare the incidence of treatment-related necrosis between combination SRS+ICI therapy and SRS therapy alone in patients with brain metastases from melanoma and non-small cell lung cancer (NSCLC). A systematic literature search of Ovid-MEDLINE...

see more →

News  4,175 results

Most Cost-effective to Use Immunotherapy First in Melanoma
https://www.medscape.com/viewarticle/941490

Nov 23rd, 2020 - Up-front immunotherapy is the most cost-effective option for treating newly diagnosed unresectable stage III or IV melanoma with unknown BRAF mutation status, concludes a modeling analysis. Investigators evaluated eight up-front options and found ...

Mitotic Rate Makes Comeback as Melanoma Prognosticator
https://www.medscape.com/viewarticle/941359

Nov 19th, 2020 - Mitotic rate, properly applied, has a prognostic impact in melanoma comparable to that of lesional ulceration, Mohammed Kashani-Sabet, MD, reported at a virtual forum on cutaneous malignancies jointly presented by Postgraduate Institute for Medici...

Low Threshold to Biopsy Atypical Lesions May ID Vulvar Melanoma Early, Experts Say
https://www.staging.medscape.com/viewarticle/941157

Nov 16th, 2020 - Having a low threshold to biopsy atypical pigmented lesions on the vulva may identify melanoma early, according to a lecture at virtual conference on diseases of the vulva and vagina, hosted by the International Society for the Study of Vulvovagin...

Low Threshold to Biopsy Atypical Lesions May ID Vulvar Melanoma Early, Experts Say
https://www.medscape.com/viewarticle/941157

Nov 16th, 2020 - Having a low threshold to biopsy atypical pigmented lesions on the vulva may identify melanoma early, according to a lecture at virtual conference on diseases of the vulva and vagina, hosted by the International Society for the Study of Vulvovagin...

What Happened to Melanoma Care During COVID-19 Sequestration
https://www.medscape.com/viewarticle/940924

Nov 12th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Initial evidence suggests that the deliberate delays in melanoma care that occurred during the COVID-19 shelter-in-place lockdown last spring had ...

see more →

Patient Education  101 results see all →